Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" report has ...
Dublin, Oct. 21, 2022 (GLOBE NEWSWIRE) -- The "Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Global Strategic Business Report" report has been added to ...
“Unveiling Future Possibilities: An In-depth Exploration of the ‘Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Trends from 2023 to 2032’ Report” Embark on an ...
Covidien's Fortrex percutaneous transluminal angioplasty balloon catheter--Courtesy of Covidien Covidien ($COV) today announced FDA 510(k) clearance for its Fortrex ...
NATICK, Mass., Boston Scientific Corporation announces the U.S. launch of its Charger™ PTA Balloon Catheter, a 0.035" percutaneous transluminal angioplasty (PTA) balloon catheter designed for a wide ...
The Percutaneous Transluminal Angioplasty Balloons Market was valued at US$ 2.1 Bn in 2022 and is projected to grow at a CAGR of 5.4% from 2022 to 2031, reaching more than US$ 3.5 Bn by 2031. Rising ...
Please provide your email address to receive an email when new articles are posted on . C.R. Bard has purchased Lutonix, manufacturer of a drug-coated percutaneous transluminal angioplasty balloon, ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced it has acquired Creagh Medical Ltd., an ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback